Literature DB >> 3137155

Two distinct signals regulate induction of IL-2 responsiveness in CD8+ murine T cells.

H Wagner1, K Heeg.   

Abstract

In the model system used here, cross-linking of T-cell receptor structures (TCR) by antigen-presenting cells (APCs) is substituted by the use of anti-F23.1 anti-T-cell receptor monoclonal antibody immobilized on Sepharose beads. We show that CR cross-linking of resting murine CD8+ T cells seeded at low cell densities is insufficient to induce responsiveness to the growth-promoting effect of interleukin-2 (IL-2), i.e. fails to induce expression of functional IL-2 receptors. The macrophage cell-line product, IL-2 receptor-inducing factor (RIF), but not IL-1, IL-3, IL-4 and interferon-gamma (IFN-gamma) functions efficiently as a co-stimulator. Once activated, growth of CD8+ T cells is driven entirely by IL-2. We conclude that two restriction points control the activation of resting CD8+ T cells. While cross-linking of TCR is essential as the first step, RIF is required as the competence factor to induce IL-2 responsiveness. We consider the possibility that the ability of APCs to produce RIF determines the immunogenicity of APCs towards antigen-reactive resting CD8+ T cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3137155      PMCID: PMC1385054     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  25 in total

1.  Synergism in the activation of human CD8 T cells by cross-linking the T-cell receptor complex with the CD8 differentiation antigen.

Authors:  F Emmrich; U Strittmatter; K Eichmann
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

Review 2.  Signal transduction in human T lymphocytes.

Authors:  D C Linch; D L Wallace; K O'Flynn
Journal:  Immunol Rev       Date:  1987-02       Impact factor: 12.988

3.  Activation of resting T lymphocytes by a monoclonal antibody directed against an allotypic determinant on the T cell receptor.

Authors:  U D Staerz; M J Bevan
Journal:  Eur J Immunol       Date:  1986-03       Impact factor: 5.532

4.  T cell receptor triggering induces responsiveness to interleukin 1 and interleukin 2 but does not lead to T cell proliferation.

Authors:  S C Meuer; K H Meyer zum Büschenfelde
Journal:  J Immunol       Date:  1986-06-01       Impact factor: 5.422

Review 5.  The role of the T3/antigen receptor complex in T-cell activation.

Authors:  A Weiss; J Imboden; K Hardy; B Manger; C Terhorst; J Stobo
Journal:  Annu Rev Immunol       Date:  1986       Impact factor: 28.527

Review 6.  T-T cell interactions during cytotoxic T lymphocyte (CTL) responses: T cell derived helper factor (Interleukin 2) as a probe to analyze CTL responsiveness and thymic maturation of CTL progenitors.

Authors:  H Wagner; C Hardt; K Heeg; K Pfizenmaier; W Solbach; R Bartlett; H Stockinger; M Röllinghoff
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

7.  Functional and biochemical characteristics of a murine interleukin 2 receptor-inducing factor.

Authors:  C Hardt; N Sato; H Wagner
Journal:  Eur J Immunol       Date:  1987-02       Impact factor: 5.532

8.  Effective activation of resting mouse T lymphocytes by cross-linking submitogenic concentrations of the T cell antigen receptor with either Lyt-2 or L3T4.

Authors:  K Eichmann; J I Jönsson; I Falk; F Emmrich
Journal:  Eur J Immunol       Date:  1987-05       Impact factor: 5.532

9.  Regulation of cytolytic T-lymphocyte generation by B-cell stimulatory factor.

Authors:  M B Widmer; K H Grabstein
Journal:  Nature       Date:  1987 Apr 23-29       Impact factor: 49.962

10.  Dendritic cells are the principal stimulators of the primary mixed leukocyte reaction in mice.

Authors:  R M Steinman; B Gutchinov; M D Witmer; M C Nussenzweig
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

View more
  1 in total

1.  Antigen-specific inhibition of IL-2 and IL-3 production in contact sensitivity to TNP.

Authors:  J Marcinkiewicz; B Chain
Journal:  Immunology       Date:  1989-10       Impact factor: 7.397

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.